Paper37745252
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications.
Satyadev N and 3 others. Front Physiol, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications. Papers, record 37745252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37745252
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References234
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12519789 | Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12519789 | PubMed |
| 2 | 34332599 | Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease. | J Transl Med | 2021 | https://conductscience.org/library/papers/34332599 | PubMed |
| 3 | 27537690 | The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy. | Ophthalmic Res | 2017 | https://conductscience.org/library/papers/27537690 | PubMed |
| 4 | 28834285 | miRNA Signatures of Insulin Resistance in Obesity. | Obesity (Silver Spring) | 2017 | https://conductscience.org/library/papers/28834285 | PubMed |
| 5 | 23619365 | MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23619365 | PubMed |
| 6 | 23335344 | The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. | Proteomics | 2013 | https://conductscience.org/library/papers/23335344 | PubMed |
| 7 | 27721418 | Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. | Sci Rep | 2016 | https://conductscience.org/library/papers/27721418 | PubMed |
| 8 | 27101382 | Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats. | PLoS One | 2016 | https://conductscience.org/library/papers/27101382 | PubMed |
| 9 | 24606996 | The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy. | Diabetol Metab Syndr | 2014 | https://conductscience.org/library/papers/24606996 | PubMed |
| 10 | 32035117 | The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectives. | Diabetes Res Clin Pract | 2020 | https://conductscience.org/library/papers/32035117 | PubMed |
| 11 | 19367702 | Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. | J Proteome Res | 2008 | https://conductscience.org/library/papers/19367702 | PubMed |
| 12 | 23635324 | Immunity, atherosclerosis and cardiovascular disease. | BMC Med | 2013 | https://conductscience.org/library/papers/23635324 | PubMed |
| 13 | 29721071 | Adipocyte-Derived Exosomal MiR-27a Induces Insulin Resistance in Skeletal Muscle Through Repression of PPARγ. | Theranostics | 2018 | https://conductscience.org/library/papers/29721071 | PubMed |
| 14 | 27680548 | Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction. | Sci Rep | 2016 | https://conductscience.org/library/papers/27680548 | PubMed |
| 15 | 428683 | Diabetes and atherosclerosis--the role of insulin. | Diabetologia | 1979 | https://conductscience.org/library/papers/428683 | PubMed |
| 16 | 26297071 | The progress in understanding and treatment of diabetic retinopathy. | Prog Retin Eye Res | 2016 | https://conductscience.org/library/papers/26297071 | PubMed |
| 17 | 17229675 | Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. | Am J Physiol Renal Physiol | 2007 | https://conductscience.org/library/papers/17229675 | PubMed |
| 18 | 29754174 | Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy. | Adv Exp Med Biol | 2018 | https://conductscience.org/library/papers/29754174 | PubMed |
| 19 | 30317615 | Insulin resistance: Review of the underlying molecular mechanisms. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30317615 | PubMed |
| 20 | 8636221 | Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. | J Cell Biol | 1996 | https://conductscience.org/library/papers/8636221 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353293 | Extracellular Vesicle-Derived MicroRNAs as Early Diagnostic Biomarkers of Diabetic Nephropathy and Cardiovascular Diseases in Type 2 Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353293 | PubMed |
| 41814272 | Harnessing exosomal long non-coding RNAs as a new frontier for molecular diagnostics and therapeutics in diabetes mellitus. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41814272 | PubMed |
| 41710719 | Promising Biomarkers for Early Diagnosis: Advances in Understanding the Pathogenesis of Diabetic Peripheral Neuropathy. | Diabetes Metab Syndr Obes | 2026 | https://conductscience.org/library/papers/41710719 | PubMed |
| 41691329 | Exosomal MicroRNAs as theranostic tools in type 2 diabetes and its complications: mechanistic insights and clinical implications. | Diabetol Metab Syndr | 2026 | https://conductscience.org/library/papers/41691329 | PubMed |
| 41303767 | Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41303767 | PubMed |
| 41075013 | Exosomes in pancreatic islet biology and diabetes: Mechanisms, Biomarkers, and potential therapeutic perspectives. | J Mol Histol | 2025 | https://conductscience.org/library/papers/41075013 | PubMed |
| 40725017 | Cord Blood Exosomal miRNAs from Small-for-Gestational-Age Newborns: Association with Measures of Postnatal Catch-Up Growth and Insulin Resistance. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725017 | PubMed |
| 40622444 | A Molecular Perspective on the Intricate Interplay Among Exosomes, Bioenergetic Metabolism, and the Pathogenesis of Diabetic Cardiomyopathy. | J Cardiovasc Transl Res | 2025 | https://conductscience.org/library/papers/40622444 | PubMed |
| 40213388 | Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40213388 | PubMed |
| 39563393 | Human studies of the efficacy and safety of stem cells in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39563393 | PubMed |
| 38932991 | Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38932991 | PubMed |
| 38615667 | Extracellular Vesicles in Metabolic and Vascular Insulin Resistance. | J Vasc Res | 2024 | https://conductscience.org/library/papers/38615667 | PubMed |
Genes94
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37745252
GET https://conductscience.org/api/papers/v1/37745252/references?page=2